Please ensure Javascript is enabled for purposes of website accessibility
Skip to main content
Focused on muscle and
positioned for growth

SEC Filing

SEC Filing Details

Document Details

Form
Filing Date
Mar 14, 2022
Document Date
Mar 11, 2022
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Dyne Therapeutics, Inc.
Issuer
DYNE THERAPEUTICS, INC.
Filer
Scalzo Richard William